Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial

Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T05:00:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T01:48:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T18:12:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed detailed descriptions of a clinical study involving Toca 511 and its treatment protocol for high-grade gliomas, while adding a new version number and a list of glioma types.
    Difference
    34%
    Check dated 2025-04-16T14:07:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T08:48:29.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-04T00:32:27.000Z thumbnail image

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.